Matthew P. Young, EVP & CFO at Jazz Pharmaceuticals plc (JAZZ), sold 5,000 shares at $170.04 ($850K) on 2018-06-01, disclosed to the SEC on 2018-06-05.
Open-market sale of $850k JAZZ by EVP & CFO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| JAZZ | SELL | 2018-11-27 | $105K | — | Filing → |
| JAZZ | SELL | 2018-10-17 | $221K | — | Filing → |
| JAZZ | SELL | 2018-09-19 | $228K | — | Filing → |